Meet the Authors: Global Pediatric Development of Drugs, Biologics, and Medical Devices

Learn how the latest RAPS book can be used to progress the availability of new therapies to prevent, diagnose and treat pediatric diseases worldwide. Four authors of Global Pediatric Development of Drugs, Biologics, and Medical Devices will discuss using the new resource to facilitate strategic discussions and foster the collaboration on pediatric plan development. The authors will describe the book illustrates the regulatory requirements, tools, incentives, pathways, and market access for drugs, biological products, and medical devices for the pediatric population.

The authors will also explain how regulatory professionals of all levels in industry, academia, or governmental agencies involved in pediatric research, pediatric drug or biologic development, and pediatric medical device development will benefit from the practical, real-life experience presented in the book.

Don’t miss this opportunity to ask the authors your questions regarding the development of drugs, biologics and medical devices for children.

Regulatory professionals of all levels in industry, academia, or governmental agencies involved in pediatric research, pediatric drug or biologic development, and pediatric medical device development.

Speakers

Jocelyn Jennings

Mycovia Pharmaceuticals, Inc.

Linda McBride

Regulatory and Compliance Consultant

Karl-Heinz Huemer, PhD, MD

Austrian Agency for Health and Food Safety (AGES)

Allison Komiyama, PhD, RAC,
Principal Consultant, Acknowledge Regulatory Strategies, LLC